| Financial Year |
March 31 2023 |
| Monetary Funds |
3,165,096,883.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
549,646,756.19 |
| Accounts Receivable |
7,734,254,472.88 |
| Advances to Suppliers |
264,894,348.72 |
| Other Receivables |
342,576,824.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
115,521,408.75 |
| Inventories |
15,097,641,707.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
656,194,494.61 |
| Total Current Assets |
27,941,986,575.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,823,673,413.93 |
| Investment Properties |
112,416,227.96 |
| Fixed Assetes |
3,708,273,705.61 |
| Under-construction Projects |
1,265,447,127.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,151,642,056.91 |
| R&D expenses |
1,022,814,888.36 |
| Goodwill |
2,176,100.99 |
| Long-Term Deferred and Prepaid Expenses |
50,590,371.81 |
| Deferred Income Tax Assets |
190,529,479.83 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
10,782,405,144.53 |
| Total Assets |
38,724,391,720.15 |
| Short-Term Loans |
2,637,795,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,048,059,859.77 |
| Accounts Payable |
5,541,571,542.42 |
| Accounts Received In Advance |
1,570,014.77 |
| Employee Compensation Payable |
455,110,214.86 |
| Taxes Payable |
357,282,759.57 |
| Interest Payable |
5,406,645.69 |
| Dividend Payable |
7,883,116.37 |
| Other payables |
2,428,197,703.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
897,201,349.79 |
| Other Current Liabilities |
192,126,959.40 |
| Sub-Total of Current Liabilities |
20,160,264,026.91 |
| Long-term Loans |
1,672,100,000.00 |
| Bonds Payable |
2,722,494,175.34 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
44,787,791.64 |
| Deferred Income Tax Liabilities |
840,981.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,994,302,406.98 |
| Total Liabilities |
25,154,566,433.89 |
| Paid-In Capital(Or Share Stock) |
1,186,564,536.00 |
| Capital Surplus |
5,876,060,312.92 |
| Surplus Reserve |
438,563,047.58 |
| LESS:Treasury Stock |
641,641,060.00 |
| Undistributed Profits |
4,589,122,796.04 |
| Minority Stockholder's Interest |
1,390,193,801.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,179,631,484.40 |
| Owner's Equity（Stockholder's Equity） |
13,569,825,286.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,724,391,720.15 |
